Literature DB >> 22393555

PURLs: Counseling is a must with this smoking cessation aid.

Luke A Stephens1, James J Stevermer.   

Abstract

For many smokers, the benefits of quitting will outweigh the risks associated with varenicline.

Entities:  

Year:  2012        PMID： 22393555      PMCID： PMC3297364     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  7 in total

1.  Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-04-21       Impact factor: 25.391

2.  Varenicline: quantifying the risk.

Authors:  Brian S Alper
Journal:  CMAJ       Date:  2011-09-06       Impact factor: 8.262

Review 3.  Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; John G Spangler; Curt D Furberg
Journal:  CMAJ       Date:  2011-07-04       Impact factor: 8.262

Review 4.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 5.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.

Authors:  Julia A Critchley; Simon Capewell
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

6.  Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.

Authors:  Nancy A Rigotti; Andrew L Pipe; Neal L Benowitz; Carmen Arteaga; Dahlia Garza; Serena Tonstad
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

7.  Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.